CFH/Fib3 binding may be just one link in a complex chain of events that progresses towards RPE pathology, photoreceptor death and blindness in some forms of AMD, but it offers the interesting possibility of a new target for therapeutic intervention that could perhaps slow the progression of this major cause of vision loss in the aging human population. The gene discussed is PCDHGA12; the disease is blindness (disorder).